Showing 1501-1510 of 2494 results for "".
- Santen Enters into a Strategic Cooperation with OFF Italia to Offer New Treatment Options to its Customers Across EMEAhttps://modernod.com/news/santen-enters-into-a-strategic-cooperation-with-off-italia-to-offer-new-treatment-options-to-its-customers-across-emea/2479663/OFF Italia and Santen entered into a licence and supply agreement with the objective to extend the offering of OFF Italia’s ophthalmic innovations to more than 30 countries across EMEA. According to the terms o
- J-Code for Glaukos’ iDose TR Becomes Activehttps://modernod.com/news/cms-j-code-for-glaukos-idose-tr-becomes-active/2482340/Glaukos announced that the CMS Healthcare Common Procedure Coding System’s J-code—J7355—for the company’s iDose TR is effective. The J-code provides patient access and streamlines the coverage and payment process as Glaukos advances its commercial launch of the treatment.<
- Novartis Receives Permanent J-code for Beovuhttps://modernod.com/news/novartis-receives-permanent-j-code-for-beovu/2477192/Novartis announced that it has received a permanent J-code for Beovu (brolucizumab-dbll) injection, effective January 1, 2020. With the permanent J-code, retina specialists may now receive more timely reimbursement for Beovu injections, facilitating access for appropriate patients to this
- New Collaboration to Produce Opticianry-Focused Educational Panel at OptiCon ’26https://modernod.com/news/new-collaboration-to-produce-opticianry-focused-educational-panel-at-opticon-26/2485385/The Contact Lens Institute (CLI) and the United Opticians Association (UOA) announced a new collaboration to co-produce "Vision for Growth: Consumer Perspectives on Opticianry & Contact Lens Success," an educational panel exclusive to OptiCon ’26 @ Vision Expo.
- US States Sue 26 Generic Drugmakers for Alleged Price Fixinghttps://modernod.com/news/us-states-sue-26-generic-drugmakers-for-alleged-price-fixing/2479522/A coalition of 51 US states and territories filed a lawsuit in federal court in Connecticut on Wednesday, accusing 26 drug companies, including Taro, Perrigo, Novartis’ Sandoz unit, Actavis, Mylan, Teva, G&W and Glenmark, of conspiring to fix prices and allocate markets for at least 80
- MPOD Measurement Earns American Medical Association CPT III Codehttps://modernod.com/news/mpod-measurement-earns-american-medical-association-cpt-iii-code/2480039/EyePromise announced that on July 1, 2018, macular pigment optical density (MPOD) measurement by heterochromatic flicker photometry has earned a Category III CPT Code from the American Medical Association. While this code does not receive paid reimbursement, Category III CPT Codes are used for da
- PDL BioPharma Files With SEC For Potential Spin-Off of Lensarhttps://modernod.com/news/pdl-biopharma-announces-filing-of-a-form-10-registration-statement-with-the-sec-for-a-potential-spin-off-of-lensar-to-pdls-stockholders/2478207/PDL BioPharma announced that its majority owned medical device subsidiary, Lensar, has filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) relating to a potential spin-off of Lensar from PDL. “Preparations for a spin-off of Lensar to PDL’
- Bausch Health to Spin Off Eye Care Businesshttps://modernod.com/news/bausch-health-to-spin-off-eye-care-business/2478131/Bausch Health Companies announced Thursday that it intends to spin off its eye health business from its core pharmaceutical business into an independent publicly traded entity called Bausch + Lomb – NewCo. The spinoff will establish two separate companies—Bausch + Lomb- NewCo, a ful
- Improved Reimbursement for Endoscopic Cyclophotocoagulation (ECP) when Combined with Cataract Surgeryhttps://modernod.com/news/improved-reimbursement-for-endoscopic-cyclophotocoagulation-ecp-when-combined-with-cataract-surgery/2477219/Beaver-Visitec International (BVI) expressed support for two new CPT codes and improved reimbursement for ECP when combined with cataract surgery. Up to 1 in 5 patients [1] undergoing cataract extraction suffers from glaucoma, and ECP remains an important option for ophtha
- Glaukos Receives Permanent J-Code for iDose TRhttps://modernod.com/news/glaukos-receives-permanent-j-code-for-idose-tr/2482208/Glaukos announced that CMS has assigned a unique, permanent J-code (J7355) for iDose TR (travoprost intracameral implant) 75 mcg, a p